MolMed and Megapharm enter into a license and distribution agreement for Zalmoxis® in Israel
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.molmed.com/sites/default/files/2019-04/3107_1493394610.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
